Neoclarity Eye And Dental Care Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-07-2024
- Paid Up Capital ₹ 2.48 M
as on 16-07-2024
- Company Age 35 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.00 M
as on 16-07-2024
- Satisfied Charges ₹ 52.40 M
as on 16-07-2024
- Revenue 43.39%
(FY 2023)
- Profit 126.03%
(FY 2023)
- Ebitda 79.93%
(FY 2023)
- Net Worth 4.78%
(FY 2023)
- Total Assets -7.01%
(FY 2023)
About Neoclarity Eye And Dental Care
The Corporate was formerly known as Essential Eye Care Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.48 M.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹5.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pradeepkumar Solanki and Ronak Solanki serve as directors at the Company.
- CIN/LLPIN
U85100MH1989PTC052272
- Company No.
052272
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Neoclarity Eye And Dental Care?
Board Members(2)
Financial Performance and Corporate Structure Insights of Neoclarity Eye And Dental Care.
Neoclarity Eye And Dental Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.39% increase. The company also saw a substantial improvement in profitability, with a 126.03% increase in profit. The company's net worth moved up by a moderate rise of 4.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neoclarity Eye And Dental Care?
In 2023, Neoclarity Eye And Dental Care had a promoter holding of 97.24% and a public holding of 2.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
9 years 5 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 18 Apr 2019 | ₹3.00 Cr | Open |
Citi Bank N.A. Creation Date: 30 Mar 2012 | ₹3.00 Cr | Satisfied |
Citibank N. A. Creation Date: 29 Mar 2008 | ₹1.59 Cr | Satisfied |
How Many Employees Work at Neoclarity Eye And Dental Care?
Unlock and access historical data on people associated with Neoclarity Eye And Dental Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 29, 2010, Neoclarity Eye And Dental Care has raised a total of ₹ 5 K, with the most recent deal valued at ₹ 5 K. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
